» Articles » PMID: 38157877

Review of Dengue, Zika and Chikungunya Infections in Nervous System in Endemic Areas

Overview
Publisher Thieme
Specialties Neurology
Psychiatry
Date 2023 Dec 29
PMID 38157877
Authors
Affiliations
Soon will be listed here.
Abstract

Dengue, zika, and chikungunya are arboviruses of great epidemiological relevance worldwide. The emergence and re-emergence of viral infections transmitted by mosquitoes constitute a serious human public health problem. The neurological manifestations caused by these viruses have a high potential for death or sequelae. The complications that occur in the nervous system associated with arboviruses can be a challenge for diagnosis and treatment. In endemic areas, suspected cases should include acute encephalitis, myelitis, encephalomyelitis, polyradiculoneuritis, and/or other syndromes of the central or peripheral nervous system, in the absence of a known explanation. The confirmation diagnosis is based on viral (isolation or RT-PCR) or antigens detection in tissues, blood, cerebrospinal fluid, or other body fluids, increase in IgG antibody titers between paired serum samples, specific IgM antibody in cerebrospinal fluid and serological conversion to IgM between paired serum samples (non-reactive in the acute phase and reactive in the convalescent). The cerebrospinal fluid examination can demonstrate: 1. etiological agent; 2. inflammatory reaction or protein-cytological dissociation depending on the neurological condition; 3. specific IgM, 4. intrathecal synthesis of specific IgG (dengue and chikungunya); 5. exclusion of other infectious agents. The treatment of neurological complications aims to improve the symptoms, while the vaccine represents the great hope for the control and prevention of neuroinvasive arboviruses. This narrative review summarizes the updated epidemiology, general features, neuropathogenesis, and neurological manifestations associated with dengue, zika, and chikungunya infection.

Citing Articles

Dengue and severe dengue with neurological complications: a challenge for prevention and control.

Francelino E, Puccioni-Sohler M Arq Neuropsiquiatr. 2024; 82(12):1-6.

PMID: 39626875 PMC: 11614563. DOI: 10.1055/s-0044-1792091.


Central and Peripheral Nervous System Manifestations Associated with Dengue Illness.

Guzman M, Martinez E Viruses. 2024; 16(9).

PMID: 39339843 PMC: 11435791. DOI: 10.3390/v16091367.


A journey through 80 years of Brazilian neurology.

Massaro A, Teive H Arq Neuropsiquiatr. 2023; 81(12):1027-1029.

PMID: 38157870 PMC: 10756812. DOI: 10.1055/s-0043-1778007.

References
1.
Singh P, Sheoran A, Tetarwal P, Singh P, Singh P . Dengue Hemorrhagic Encephalitis in Dengue Epidemic. J Glob Infect Dis. 2023; 15(1):37-38. PMC: 10118216. DOI: 10.4103/jgid.jgid_147_22. View

2.
Nikookar S, Fazeli-Dinan M, Enayati A, Zaim M . Zika; a continuous global threat to public health. Environ Res. 2020; 188:109868. DOI: 10.1016/j.envres.2020.109868. View

3.
Bernardo-Menezes L, Agrelli A, de Oliveira A, Rodrigues de Moura R, Crovella S, Brandao L . An overview of Zika virus genotypes and their infectivity. Rev Soc Bras Med Trop. 2022; 55:e02632022. PMC: 9536801. DOI: 10.1590/0037-8682-0263-2022. View

4.
Cerny T, Schwarz M, Schwarz U, Lemant J, Gerardin P, Keller E . The Range of Neurological Complications in Chikungunya Fever. Neurocrit Care. 2017; 27(3):447-457. DOI: 10.1007/s12028-017-0413-8. View

5.
Chopra A, Anuradha V, Ghorpade R, Saluja M . Acute Chikungunya and persistent musculoskeletal pain following the 2006 Indian epidemic: a 2-year prospective rural community study. Epidemiol Infect. 2011; 140(5):842-50. DOI: 10.1017/S0950268811001300. View